The novel therapy of the medication represents a exciting advance in the management of diabetes mellitus type 2. Different to existing medications, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatidepeptide949157.loginblogin.com/50222513/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment